Improving Prior Authorization in Medicare Advantage

Kelly E Anderson; Michael Darden; Amit Jain

doi:10.1001/jama.2022.17732

Improving Prior Authorization in Medicare Advantage

JAMA. 2022 Oct 18;328(15):1497-1498. doi: 10.1001/jama.2022.17732.

Authors

Kelly E Anderson^{1

2}, Michael Darden^{3

4}, Amit Jain^{2

5}

Affiliations

¹ Anschutz Medical Campus, University of Colorado, Aurora.
² Hopkins Business of Health Initiative, Johns Hopkins University, Baltimore, Maryland.
³ Carey Business School, Johns Hopkins University, Baltimore, Maryland.
⁴ National Bureau of Economic Research, Cambridge, Massachusetts.
⁵ School of Medicine, Johns Hopkins University, Baltimore, Maryland.

PMID: 36190725
DOI: 10.1001/jama.2022.17732

No abstract available

Plain language summary

This Viewpoint discusses the potential benefits and harms of prior authorization in Medicare Advantage and the health policy implications and opportunities for improvement.

Publication types

Research Support, N.I.H., Extramural

MeSH terms

Medicaid
Medicare Part C* / standards
Prior Authorization* / standards
Quality Improvement* / standards
United States

Grants and funding

R01 AR080315/AR/NIAMS NIH HHS/United States